- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05274009
Protective Cooling Measures to Safeguard Elderly People From Dangerous Summer Heat
October 19, 2022 updated by: Glen P. Kenny, University of Ottawa
Evaluating the Efficacy of Cooling Centres for Limiting Heat Strain in Elderly Adults During Extreme Heat Events
With the increasing incidence and severity of extreme heat events accompanying climate change, there is an urgent need for sustainable cooling strategies to protect heat-vulnerable older adults, who are at increased risk of adverse health events during heat stress.
Health agencies including the World Health Organization, the United States Centers for Disease Control and Prevention, and Health Canada currently recommend visiting a cooling centre or other air-conditioned location for 1-3 hours per day during extreme heat events to mitigate hyperthermia and strain on the cardiovascular system and therefore the risk adverse health events.
However, our recent trial shows that while brief air-conditioning exposure is effective for reducing body temperature and cardiovascular burden in healthy older adults, the physiological impacts of cooling abate quickly following return to the heat.
The purpose of this project is therefore to assess whether shorter but more frequent air-conditioning exposure provides more effective cooling than current recommendations (a single 1-3-hour cooling bout) in older adults with or without common chronic health conditions associated with increased vulnerability to extreme heat.
This will be accomplished by evaluating physiological strain in older adults with and without diabetes and/or hypertension exposed for 8 hours to conditions reflective of extreme heat events in temperate, continental climates (35°C, 60% relative humidity).
Participants will complete 3 separate simulated heat event exposures: i) a control trial (no cooling throughout the 8-hour heat event); ii) a recommended cooling trial (3 hours of heat exposure followed by 2 hours cooling); and iii) a hybrid cooling trial (2 hours of heat exposure followed by 1 hour cooling, another 2 hours heat exposure followed by 1 hour cooling, and a final 2-hour heat exposure).
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Glen P Kenny, PhD
- Phone Number: 4282 6135625800
- Email: gkenny@uottawa.ca
Study Contact Backup
- Name: Robert D Meade, PhD
- Phone Number: 6136986071
- Email: rmead015@uottawa.ca
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N6N5
- University of Ottawa
-
Contact:
- Glen P Kenny, PhD
- Phone Number: 4282 6135625800
- Email: gkenny@uottawa.ca
-
Contact:
- Robert D Meade, PhD
- Phone Number: 6136986071
- Email: rmead015@uottawa.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult aged 60-85 years
- Male or female
- Body mass index < 35 kg/m2
- For participants with type 2 diabetes: at least one year lapsed since diagnosis and hemoglobin A1c 6.0-10.5%.
- For participants with hypertension: at least one year lapsed since diagnosis or average resting blood pressure >140 systolic or >90 diastolic
Exclusion Criteria:
- Currently smoking or quit <5 years ago
- Moderate or serious medical conditions (other than Type 2 diabetes or high blood pressure), particularly those known to influence physiological responses to heat exposure (e.g., diagnosed heart disease, neurological disorders)
- Heat adapted due to repeated exposure to hot environments (use sauna, recent travel to hot climates, other)
- For participants with type 2 diabetes: "Brittle" diabetes: unpredictable hypo- & hyperglycemia. Severe cardiovascular autonomic or peripheral neuropathy (guidelines.diabetes.ca/cpg)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Extreme heat event simulation + no cooling (control)
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
|
Participants are exposed to 35°C, 60% relative humidity for 8 hours.
|
Experimental: Extreme heat event simulation + recommended cooling
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
|
Participants are exposed to 35°C, 60% relative humidity for 3 hours, are then moved to an air-conditioned room for 2 hours (~23°C, ~50% relative humidity), and then return to the heat for a final 3 hours.
|
Experimental: Extreme heat event simulation + hybrid cooling
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
|
Participants are exposed to 35°C, 60% relative humidity for 2 hours, are moved to an air-conditioned room for 1 hour (~23°C, ~50% relative humidity), return to the heat for 2 hours, move back to the air-conditioned room for 1 hour, and then return to the heat for a final 2 hours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Core temperature (peak)
Time Frame: 8-hour heat exposure
|
Peak rectal temperature measured during the 8-hour heat exposure.
|
8-hour heat exposure
|
Core temperature (AUC)
Time Frame: 8-hour heat exposure
|
Rectal temperature will be measured continuously throughout each exposure and the area under the curve will be calculated.
|
8-hour heat exposure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate temperature (peak)
Time Frame: 8-hour heat exposure
|
Peak rectal temperature measured during the 8-hour heat exposure.
|
8-hour heat exposure
|
Heart rate (AUC)
Time Frame: 8-hour heat exposure
|
Heart rate will be measured continuously throughout each exposure and the area under the curve will be calculated.
|
8-hour heat exposure
|
Mean skin temperature
Time Frame: Before and continuously throughout each 8 hour exposure
|
Mean skin temperature calculated as a weighted average of skin temperatures at 8 body regions.
|
Before and continuously throughout each 8 hour exposure
|
Arterial blood pressures
Time Frame: Every hour during the 8-hour heat exposure
|
Systolic and diastolic pressures measured in triplicate.
|
Every hour during the 8-hour heat exposure
|
SDNN
Time Frame: Every hour during the 8-hour heat exposure
|
Standard deviation of normal-to-normal R-R intervals measured via 3-lead ECG.
|
Every hour during the 8-hour heat exposure
|
RMSSD
Time Frame: Every hour during the 8-hour heat exposure
|
Root mean squared standard deviation of normal-to-normal R-R intervals measured via 3-lead ECG.
|
Every hour during the 8-hour heat exposure
|
Rate pressure product
Time Frame: Every hour during the 8-hour heat exposure
|
Rate pressure product calculated as systolic blood pressure x heart rate.
|
Every hour during the 8-hour heat exposure
|
Body fluid loss
Time Frame: Every hour during the 8-hour heat exposure
|
Body fluid loss calculated as a change in body weight from pre-exposure values (corrected for food intake and deification).
|
Every hour during the 8-hour heat exposure
|
Stand test: 30:15 ratio
Time Frame: Prior to and following the 8-hour heat exposure
|
30:15 ratio calculated as the ratio of the RR interval measured after 30 heart beats following standing from a supine position to that measured after 15 heart beats.
|
Prior to and following the 8-hour heat exposure
|
Stand test: Systolic response to standing
Time Frame: Prior to and following the 8-hour heat exposure
|
Fall in systolic blood pressure after standing from a supine position.
|
Prior to and following the 8-hour heat exposure
|
Baroreflex sensitivity
Time Frame: Prior to and following the 8-hour heat exposure
|
Baroreflex sensitivity determined during cyclic stand-squat manoeuvres.
|
Prior to and following the 8-hour heat exposure
|
Change in plasma volume
Time Frame: Prior to and following the 8-hour heat exposure
|
Change in plasma volume calculated from venous blood samples (Dill and Costill technique)
|
Prior to and following the 8-hour heat exposure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Glen P Kenny, PhD, University of Ottawa
- Principal Investigator: Ronald J Sigal, MD, MPH, University of Calgary
- Principal Investigator: Robert D Meade, PhD, University of Ottawa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2023
Primary Completion (Anticipated)
May 1, 2024
Study Completion (Anticipated)
May 1, 2024
Study Registration Dates
First Submitted
February 25, 2022
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 10, 2022
Study Record Updates
Last Update Posted (Actual)
October 21, 2022
Last Update Submitted That Met QC Criteria
October 19, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-11-21-7566
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Deidentified participant data will be available from Dr. Kenny upon reasonable request and signed access agreement.
IPD Sharing Time Frame
After study completion
IPD Sharing Access Criteria
Reasonable request and signed access agreement
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
Clinical Trials on No cooling (control)
-
University of OttawaRecruitingHyperthermia | Aging | Heat Stress | CoolingCanada
-
University of OttawaCompletedHyperthermia | Aging | Heat Stress | Weather; Heat | Heat SyncopeCanada
-
University of OttawaCompletedHyperthermia | Aging | Heat Stress | Weather; HeatCanada
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaUnknownPulseless Electrical Activity | Asystole | Postcardiac ArrestCanada
-
National Taiwan Sport UniversityMinistry of Science and Technology, TaiwanCompletedDecline, CognitiveTaiwan
-
Hasselt UniversityUnknownStroke | Aortic Valve StenosisBelgium
-
BeneChill, IncCompletedCardiac ArrestBelgium, Germany, Czech Republic, Italy, Sweden
-
Lawson Health Research InstituteWestern University, CanadaCompletedCardiac Arrest | Anoxic Brain InjuryCanada
-
Stanford UniversityInspiration HealthcareCompleted
-
ZOLL Circulation, Inc., USAPhilips Healthcare; Lund University HospitalCompletedAcute Anterior Myocardial InfarctionSweden